Departamento de Química, Facultad de Farmacia, Universidad San Pablo, Madrid, Spain.
Biopolymers. 2012 Jan;97(1):45-53. doi: 10.1002/bip.21700. Epub 2011 Aug 9.
Adrenomedullin (AM) is a regulatory peptide which plays many physiological roles including vasodilatation, bronchodilatation, hormone secretion regulation, growth, apoptosis, angiogenesis, and antimicrobial activities, among others. These regulatory activities make AM a relevant player in the pathophysiology of important diseases such as cardiovascular and renal conditions, cancer, and diabetes. Therefore, molecules that target the AM system have been proposed as having therapeutic potential. To guide the design and characterization of such molecules, we elucidated the three-dimensional structure of AM in a membrane mimicking medium using NMR spectroscopy methods. Under the employed experimental conditions, the structure can be described as composed by a central α-helical region, spanning about one third of its total length, flanked by two disordered segments at both N- and C-termini. The structure of AM in water is completely disordered. The 22-34 region of AM has a general tendency to adopt a helical structure under the employed experimental conditions. Furthermore, the study of the interaction of AM with two of its modulators has also been performed by using chemical shift perturbation analysis NMR methods with two-dimensional (2D)-TOCSY experiments, assisted with molecular modeling protocols. We expect these results will help in better understanding the interactions of AM with its receptor and binding proteins/molecules and in the development of novel modulators of AM activities.
肾上腺髓质素(AM)是一种调节肽,具有多种生理作用,包括血管舒张、支气管舒张、激素分泌调节、生长、凋亡、血管生成和抗菌活性等。这些调节作用使 AM 成为心血管和肾脏疾病、癌症和糖尿病等重要疾病病理生理学的相关参与者。因此,靶向 AM 系统的分子被认为具有治疗潜力。为了指导这些分子的设计和表征,我们使用 NMR 光谱方法在模拟膜的介质中阐明了 AM 的三维结构。在采用的实验条件下,该结构可描述为由大约三分之一总长度的中央α-螺旋区域组成,其两端为 N-和 C-末端的两个无序片段。AM 在水中的结构完全无序。在采用的实验条件下,AM 的 22-34 区域具有普遍的螺旋结构倾向。此外,还使用化学位移扰动分析 NMR 方法和二维(2D)TOCSY 实验,辅助分子建模方案,研究了 AM 与其两种调节剂的相互作用。我们希望这些结果将有助于更好地理解 AM 与其受体和结合蛋白/分子的相互作用,并开发 AM 活性的新型调节剂。